14th March 2018

Pharmaceutical Startup, Bridge Therapeutics, Announces Tim Peara Will Be Joining the Company as the Director of Finance

The innovative late development-stage pharmaceutical startup, Bridge Therapeutics has announced Tim Peara will be joining its management team as the new Director of Finance, effective immediately.

Tim Peara has more than 30 years of experience with institutional investments and technology start-ups. He has negotiated and structured investments, conducted due diligence, and built financial models for companies in finance, energy tech, and industry. Mr. Peara has also built and led teams while consulting to a variety of businesses.

Tim holds a BA in Latin American Studies from Wesleyan University in Connecticut and an MBA in Finance & International Business from the University of Chicago’s Booth School of Business.

For more information about Bridge Therapeutics please contact us today using the form below.